Shishido Hideo | Third Department Of Internal Medicine Dokkyo University School Of Medicine
スポンサーリンク
概要
- SHISHIDO Hideoの詳細を見る
- 同名の論文著者
- Third Department Of Internal Medicine Dokkyo University School Of Medicineの論文著者
関連著者
-
SUGIYAMA Haruo
Departments of Clinical Laboratory Science
-
OJI Yusuke
Departments of Clinical Laboratory Science
-
OKA Yoshihiro
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
TSUBOI Akihiro
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
Kami Masahiro
Jr東京総合病院 血液内科
-
Sao Hiroshi
Department of Hematology, Meitetsu Hospital
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
KAWAKAMI Manabu
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
Soma Toshihiro
大阪大学 医学系研究科
-
Soma Toshihiro
Medicine Iii Osaka University Medical School
-
Soma T
Department Of Medicine National Hospital Organization Osaka Minami Medical Center
-
NISHIDA Sumiyuki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
Kami Masahiro
Division Of Exploratory Research Institute Of Medical Science University Of Tokyo
-
小嶋 哲人
Department Of Transfusion Medicine Cardiology And Hematology Nagoya University Hospital
-
小嶋 哲人
名古屋大学医学部第一内科
-
小嶋 哲人
名古屋大学 保健
-
三木 義男
癌研ゲノムセンター
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
KAWASE Ichiro
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
HOSEN Naoki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Seto M
Department Of Hematology And Chemotherapy
-
坂本 弘明
Department of Internal Medicine II, Fukushima Medical University, School of Medicine
-
Seto Masao
東京大学医学部附属病院 無菌治療部
-
斉藤 広信
福島県立医科大学 医学部内科学第二講座
-
TAWARA Masayuki
Nagasaki CML Study Group
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
KOJIMA Tetsuhito
Department of Medical Technology, Nagoya University School of Health Sciences
-
Seto Masao
愛知県がんセンター研究所 分子腫瘍学部
-
Iida Hiroatsu
Department of Hematology, Meitetsu Hospital
-
MATSUSHITA Tadashi
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
SAITO Hidehiko
Nagoya Central Hospital
-
KODERA Yoshihisa
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
OGAWA Hiroyasu
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
OHNO Ryuzo
Aichi Cancer Center
-
KOHNO Akio
Department of Hematology and Oncology JA Aichi Konan Kosei Hospital
-
IKEGAME Kazuhiro
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
MASUDA Tomoki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
Tsuboi Naoya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
SAKAMAKI Hisashi
Division of Hematology, Tokyo Metropolitan Komagome Hospital
-
AOZASA Katsuyuki
Department of Pathology, Osaka University Graduate School of Medicine
-
MIYAZAKI Yasushi
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
Ogata Kentaro
Faculty of Pharmaceutical Sciences, Fukuoka University
-
Hara Shuuji
Faculty of Pharmaceutical Sciences, Fukuoka University
-
谷脇 雅文
高知工科大学工学部
-
MORI Shinichiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Tobinai Kensei
国立がんセンター中央病院 血液内科グループ
-
Tobinai Kensei
東海大学 医学部
-
Katayama Y
Division Of Hematology Saitama Medical Center Jichi Medical University
-
TOMONAGA Masao
Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine
-
TAKAGI Akira
Department of Medical Technology, Nagoya University School of Health Sciences
-
MORISHITA Yoshihisa
Department of Hematology and Oncology JA Aichi Konan Kosei Hospital
-
KIM Eui
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
MUKUBO Masaaki
Yodogawa Christian Hospital
-
MURAKAMI Masaki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
Miura S
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
Kojima M
Department Of Anatomic And Diagnostic Pathology Dokkyo University School Of Medicine
-
HATA Tomoko
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
IMANISHI Daisuke
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
OHTAKE Shigeki
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
Takamatsu Yasushi
First Department of Internal Medicine, Fukuoka University
-
Tamura Kazuo
First Department of Internal Medicine, Fukuoka University
-
Kunitomi Akane
Department of Hematology, Meitetsu Hospital
-
Kamiya Yoshikazu
Department of Hematology, Meitetsu Hospital
-
永井 正
自治医科大学内科学講座血液学部門
-
ANDO KOJI
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University
-
吉川 秀樹
大阪大学大学院医学系研究科器官制御外科学(整形外科)
-
NAKAYAMA Takayuki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
MIYAMURA Koichi
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
Miyazaki Yoshitsugu
長崎大学 第二内科
-
Yokota Asumi
大阪大学 医系研究 病態生体情報学
-
Yokota Asumi
Department Of Functional Diagnostic Science Osaka University Graduate School Of Medicine
-
TSUKASAKI Kunihiro
Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine
-
MATSUO Yuzi
the Department of Laboratory Midicine
-
SAWA Masashi
Department of Hematology, Anjo Kosei Hospital
-
吉川 秀樹
大阪大学大学院医学系研究科器官制御外科学
-
TATEKAWA Toyoshi
Medicine III, Osaka University Medical School
-
TAMAKI Hiroya
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
SOMA Toshihiro
Department of Medicine, National Hospital Organization Osaka Minami Medical Center
-
FUJIOKA Tatsuya
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
TANIGUCHI Yuki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
SUZUKI Ritsuro
Department of HSCT Data Management, Nagoya University Hospital
-
SHIMOYAMA Masanori
National Cancer Center Hospital
-
永井 正
自治医科大学 内科学講座血液学部門
-
岡田 昌也
兵庫医科大学総合内科学血液・腫瘍科
-
Seto M
Aichi Cancer Center Res. Inst. Nagoya
-
Yamamoto Koji
Department of Internal Medicine, Hattori Memorial Hospital
-
Ogawa Daisuke
Nagasaki Cml Study Group
-
MATSUO Keitaro
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute
-
SAKAI Mari
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
MATSUO Emi
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
MORIUCHI Yukiyoshi
Nagasaki CML Study Group
-
FUKUSHIMA Takuya
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
IMAIZUMI Yoshitaka
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
TAGUCHI Jun
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
IWANAGA Masako
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
TSUSHIMA Hideki
Nagasaki CML Study Group
-
INOUE Yoriko
Nagasaki CML Study Group
-
TAKASAKI Yumi
Nagasaki CML Study Group
-
NAGAI Kazuhiro
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
TSUTSUMI Chizuko
Nagasaki CML Study Group
-
SAWAYAMA Yasushi
Nagasaki CML Study Group
-
YAMASAKI Reishi
Nagasaki CML Study Group
-
KAWAGUCHI Yasuhisa
Nagasaki CML Study Group
-
IKEDA Shuichi
Nagasaki CML Study Group
-
YOSHIDA Shinichiro
Nagasaki CML Study Group
-
ONIMARU Yasuyuki
Nagasaki CML Study Group
-
ATOGAMI Sunao
Nagasaki CML Study Group
-
JOH Tatsuro
Nagasaki CML Study Group
-
YOSHIMINE Toshiki
Department of Neurosurgery, Osaka University Medical School
-
Honda Sumihisa
Department of Public Health, Nagasaki University Graduate School of Biomedical Sciences
-
AKIYAMA Hideki
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
SAKAMAKI Hisashi
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
UEDA Ryuzo
Department of Medical Oncology and Immunology, Nagoya City University Graduate School of Medical Sci
-
YAGASAKI Fumiharu
Department of Hematology, Saitama Medical University Hospital
-
MIYAWAKI Shuichi
Division of Hematology, Saiseikai Maebashi Hospital
-
MATSUDA Shin
Center for Hematopoietic Disorders, Ohta Nishinouchi Hospital, The Ohta Foundation
-
KISHIMOTO Yuji
The First Department of Internal Medicine, Kansai Medical University
-
TAKAHASHI Masatomo
Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School
-
ASOU Norio
Department of Hematology, Kumamoto University School of Medicine
-
ETO Tetsuya
Department of Hematology, Hamanomachi Hospital
-
TAMURA Kazuo
Division of Medical Oncology and Hematology, Department of Medicine, Fukuoka University Hospital
-
SUZUMIYA Junji
Department of Internal Medicine, Fukuoka University Chikushi Hospital
-
EMI Nobuhiko
Department of Hematology, Fujita Health University
-
MITANI Kinuko
Department of Hematology, Dokkyo University School of Medicine
-
MIYAZAKI Yasushi
The Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University School of Medicine
-
OGAWA Yoshiaki
Department of Hematology and Oncology, Tokai University School of Medicine
-
Takase Daizi
Faculty of Pharmaceutical Sciences, Fukuoka University
-
Matsumoto Taichi
Faculty of Pharmaceutical Sciences, Fukuoka University
-
Jimi Shiro
Central Laboratory of Pathology and Morphology, Fukuoka University
-
Hayashi Mayuko
Department of Hematology, Meitetsu Hospital
-
清水 隆之
慶應義塾大学医学部血液内科
-
TAKAMATSU Yasushi
Division of Oncology, Hematology, and Infectious Diseases, Department of Medicine, Fukuoka Universit
-
桜井 幹己
大阪大学病理部
-
YOSHIKAWA Hideki
Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine
-
桜井 幹己
大阪市立大学医学部第2病理
-
TAKAMI Akiyoshi
Department of Cellular Transplantation Biology, Kanazawa University Graduate School of Medicine
-
MURAYAMA Tohru
Department of Hematology, Hyogo Medical Center for Adults
-
KAMI Masahiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
SONG Kyung
Department of Gastroenterology, Kobe Asahi Hospital
-
OGURA Michinori
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
HOTTA Tomomitsu
Department of Hematology and Oncology, Tokai University School of Medicine
-
Adachi Yoshihiro
Department of Materials Engineering, Graduate School of Engineering, The University of Tokyo
-
TSUCHIDA Masahiro
Department of Pediatrics, Ibaraki Children's Hospital
-
Kawano Kiyoshi
Department Of Clinical Pathology Osaka Rosai Hospital
-
Kawano Kiyoshi
大阪大学 大学院 医学系研究科 保健学専攻 機能診断科学 講座
-
Kawano Kiyoshi
Department Of Pathology Osaka Rosai
-
OGAWA Daisuke
Department of Medicine and Clinical Science (Internal Medicine III), Okayama University Graduate Sch
-
INOUE Masakazu
Department of Pediatrics, Yamada Red-Cross Hospital
-
Takeuchi Kengo
Department Of Pathology Cancer Institute Japanese Foundation For Cancer Research
-
FUJIWARA TOHRU
Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine
-
OHASHI Haruhiko
Clinical Research Center for Blood Disease, National Hospital Organization Nagoya Medical Center
-
CHOI Yong
Department of Advanced Materials Engineering, Sunmoon University
-
MONDEN Morito
Department of Surgery and Clinical Oncology, Osaka University Graduate School of Medicine
-
MORITA Satoshi
Department of Young Leaders' Program in Health Care Administration, Nagoya University Graduate Schoo
-
SAKAMOTO Junichi
Department of Young Leaders' Program in Health Care Administration, Nagoya University Graduate Schoo
-
KAWA Keisei
Department of Hematology/Oncology, Osaka Medical Center and Research Institute for Maternal and Chil
-
YOSHIDA Takashi
Department of Pharmacognosy, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Oka
-
INOHARA HIDENORI
Department of Radiation Biology, Faculty of Medicine, Osaka University
-
OKADA Hiromi
Department of Hemostasis and Thrombosis, Clinical Research Center, Nagoya Medical Center
-
TOYODA Yoshimi
Department of Medical Technology, Nagoya University School of Health Sciences
-
YAMAZAKI Tomio
Department of Hemostasis and Thrombosis, Clinical Research Center, Nagoya Medical Center
-
NISHIWAKI Satoshi
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
TERAKURA Seitaro
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
YASUDA Takahiko
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
IMAHASHI Nobuhiko
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
NIIMI Keiko
Department of Hematology, Meitetsu Hospital
-
YOKOZAWA Toshiya
Clinical Research Center, National Hospital Organization Nagoya Medical Center
-
OKA Yoshihiro
Medicine III, Osaka University Medical School
-
MATSUNASHI Tatsuro
Medicine III, Osaka University Medical School
-
YAMAGAMI Tamotsu
Medicine III, Osaka University Medical School
-
TSUBOI Akihiro
Medicine III, Osaka University Medical School
-
TAMAKI Hiroya
Medicine III, Osaka University Medical School
-
KIM Eui
Medicine III, Osaka University Medical School
-
OGAWA Hiroyasu
Medicine III, Osaka University Medical School
-
YAMAGAMI Tamotsu
Department of Medicine, National Hospital Organization Osaka Minami Medical Center
-
MISHIMA Machiko
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
OSUMI Kazuoki
Otsuka Pharmaceutical Co. Ltd.
-
TATEKAWA Toyoshi
Department of Medicine III, Osaka University Medical School
-
ASADA Momotaro
Department of Clinical Laboratory Science, Osaka University Medical School
-
KISHIMOTO Tadamitsu
Osaka University
-
Nagane Yutaka
東京大学医科学研究所ヒトゲノム解析センター
-
OHNISHI Kazunori
Department of Internal Medicine, Hamamatsu University School of Medicine
-
KOJIMA Masaru
Department of Anatomic and Diagnostic Pathology, Dokkyo University School of Medicine
-
YAMAMOTO HIROFUMI
Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
-
Ueda R
Department Of Medical Oncology And Immunology Nagoya City University Graduate School Of Medical Scie
-
KOJIMA Hiroshi
Department of Hematology, Institute of Clinical Medicine, University of Tsukuba
-
Matsushita Tadashi
Department Of Pathophysiological Laboratory Sciences Nagoya University Graduate School Of Medicine
-
Murate Takashi
Department Of Medical Technology Nagoya University Graduate School Of Health Sciences
-
TANIGUCHI Shuichi
Department of Hematology, Toranomon Hospital
-
TSUCHIYA Takeshi
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
KOMODA Minori
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
HORIO Kensuke
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
MORIWAKI Yuji
Nagasaki CML Study Group
-
TOMINAGA Shinya
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
ITONAGA Hidehiro
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
KOIDA Satoshi
Nagasaki CML Study Group
著作論文
- A SIMPLE AND SELECTIVE HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF PARAQUAT AND DIQUAT IN HUMAN URINE
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- Activated protein C resistance in the Japanese population due to homozygosity for the factor V R2 haplotype
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Successful treatment of relapsed T-cell non-Hodgkin's lymphoma with allogeneic peripheral blood stem cell transplantation with double conditioning
- Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)
- Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Recurrent Mutations of Factor XI Gene in Japanese
- Structural Organization and Promoter Activity of the Human Ryudocan Gene
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Recurrent Intramural Hematoma of the Small Intestine in a Severe Hemophilia A Patient with a High Titer of Factor VIII Inhibitor : A Case Report and Review of the Literature
- High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
- Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
- High frequencies of less differentiated and more proliferative WT1-specific CD8^+ T Cells in bone marrow in tumor-bearing patients : An important role of bone marrow as a secondary lymphoid organ
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8^+ T cells in patients with myeloid malignancies
- Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
- Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
- Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma
- Individual Dose Adjustment of Oral Busulfan Using a Test Dose in Hematopoietic Stem Cell Transplantation
- Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
- A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial
- Impact of Cytogenetics on Outcome of Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission : A Large-Scale Retrospective Analysis of Data from the Japan Society for Hematopoietic Cell Transplantation
- Quality of Life in Adult Patients After Stem Cell Transplantation
- Molecular remission achieved by interferon therapy in a patient with cytogenetically relapsed chronic myelogenous leukemia after syngeneic bone marrow transplantation
- Successful treatment using tacrolimus ointment for cutaneous graft-versus-host disease
- Low-Dose Cyclosporin A with Short-Term Methotrexate for Graft-versus-Host Disease Prophylaxis in Allogeneic Bone Marrow Transplantation from Human Leukocyte Antigen-Identical Siblings : A Prospective Phase II Study in Japanese Patients
- Twenty Years' Experience in Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Nagoya Blood and Marrow Transplantation Group
- Classic Polyarteritis Nodosa Presenting Rare Clinical Manifestations in a Patient with Hemophilia A
- Identification of the regulatory elements of the human von Willebrand factor for binding to platelet GPIb. Importance of structural integrity of the regions flanked by the CYS1272-CYS1458 disulfide bond
- Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions
- Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1
- Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors
- Wilms Tumor Gene WT1 Peptide-Based Immunotherapy Induced a Minimal Response in a Patient with Advanced Therapy-Resistant Multiple Myeloma
- WT1_, a Ninemer Peptide Derived from Wilms' Tumor Gene Product, Is a Candidate Peptide for the Vaccination of HLA-A^*0201-Positive Patients with Hematopoietic Malignancies
- WT1 Peptide-Based Immunotherapy for Patients with Lung Cancer : Report of Two Cases
- Wilms Tumor Gene Peptide-Based Immunotherapy for Patients with Overt Leulemia from Myelodysplastic Syndrome (MDS) or MDS with Myelofibrosis
- Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro
- Genetic Abnormalities of Bernard-Soulier Syndrome
- WT1 (Wilms' Tumor 1) Peptide Immunotherapy for Renal Cell Carcinoma
- Overexpression of the Wilms′tumor gene WT1 in head and neck squamous cell carcinoma
- Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies
- Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors
- Interferon-α and zidovudine for relapsed/refractory adult T cell leukemia/lymphoma : case reports of Japanese patients
- Identification of a WT1 protein-derived peptide, WT1_, : as a HLA-A^*0206-restricted, WT1-specific CTL epitope
- A WT1 protein-derived, naturally processed 16-mer peptide, WT1_, is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4^+ T cells
- Unrelated Bone Marrow Transplantation Induced Long-Term Remission in a Patient with Life-Threatening Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis